What IP Attys Should Know About Enablement After Amgen
The same patent enablement standard that has existed for centuries must be applied to modern antibody patents, the U.S. Supreme Court ruled last week, prompting attorneys to review current patents and...To view the full article, register now.
Already a subscriber? Click here to view full article